Regulators, marketers seek to clarify pharma's marketing role on social media at hearings

Share this article:

Federal regulators and pharmaceutical company marketers sought to clear up regulations for online and social media marketing strategies at the Food and Drug Administration's November 12 hearings on the topic.

The testimony addressed four questions: for what online communications should manufacturers, packagers or distributors be accountable; how companies can fulfill regulatory requirements on the Internet and social media in light of space limitations and real-time tools; what parameters should apply to the posting of corrective information on sites controlled by third parties; and when the use of links is appropriate.

Executives from J&J and Sanofi-Aventis offered specific thoughts on where the FDA could allow links, corporate responsibility for content and what might constitute adequate provision of risk information within space-limited formats like Twitter.

Click here to read Medical Marketing and Media's full coverage of the hearings.

Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Digital Marketing

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Digital Marketing

Mobile Spend Vaults 76 Percent in First Half, IAB Reports

Mobile Spend Vaults 76 Percent in First Half, ...

Overall Internet ad revenues escalate by 15% to $23 billion, also fueled by increased activity in social media and video.

Top 20 Percent Is Twice as Good at Converting as the Rest

Top 20 Percent Is Twice as Good at ...

There are five reasons elite marketers trounce the competition: testing, targeting, spending, mobilizing, and democratizing.

Ecstatic Over Programmatic

Ecstatic Over Programmatic

Ads purchased programmatically will double this year to $10 billion, and then again to $20 billion in 2016, a new study forecasts.